A61P 25/06
Antimigraine agents
A61P25/06 (Antimigraine agents) appears on 5,822 US grants and 8,323 published applications in this corpus.
Search patents in A61P- Granted patents
- 5,822
- Published applications
- 8,323
- Assignees
- 1,805
- Inventors
- 11,918
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 1 | 0 |
| 1980 | 2 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 4 | 0 |
| 1986 | 6 | 0 |
| 1987 | 2 | 0 |
| 1988 | 3 | 0 |
| 1989 | 11 | 0 |
| 1990 | 12 | 0 |
| 1991 | 15 | 0 |
| 1992 | 13 | 0 |
| 1993 | 15 | 0 |
| 1994 | 20 | 0 |
| 1995 | 28 | 0 |
| 1996 | 27 | 0 |
| 1997 | 55 | 0 |
| 1998 | 51 | 0 |
| 1999 | 70 | 0 |
| 2000 | 90 | 0 |
| 2001 | 105 | 37 |
| 2002 | 165 | 231 |
| 2003 | 156 | 375 |
| 2004 | 165 | 491 |
| 2005 | 166 | 430 |
| 2006 | 242 | 471 |
| 2007 | 222 | 477 |
| 2008 | 242 | 521 |
| 2009 | 281 | 601 |
| 2010 | 353 | 702 |
| 2011 | 381 | 521 |
| 2012 | 399 | 523 |
| 2013 | 422 | 378 |
| 2014 | 403 | 326 |
| 2015 | 272 | 347 |
| 2016 | 233 | 236 |
| 2017 | 240 | 280 |
| 2018 | 170 | 220 |
| 2019 | 158 | 189 |
| 2020 | 133 | 195 |
| 2021 | 112 | 174 |
| 2022 | 90 | 144 |
| 2023 | 82 | 139 |
| 2024 | 77 | 118 |
| 2025 | 76 | 122 |
| 2026 | 46 | 75 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Nucleic acids encoding humanized anti-PACAP antibodies29 Sep 2026US 12,747,291 B2H. Lundbeck A.S.
- Compositions comprising cannabinoids and methods of use thereof18 Aug 2026US 12,708,631 B2Schedule 1 Therapeutics, Inc.
- Compositions and methods for treatment of headache disorders and neuropathic pain11 Aug 2026US 12,702,697 B2Washington University
- Tetrahydroisoquinoline compound as potassium channel modulator and preparation and application thereof11 Aug 2026US 12,703,687 B2Shanghai Zhimeng Biopharma, Inc.
- Kv1.3 antagonists for use in the treatment of chronic and acute pain4 Aug 2026US 12,697,321 B2Sea4US - Biotecnologia E Recursos Marinhos, Lda.
- Treatment of pain8 Oct 2026US 2026/0306596 A1Ipsen Biopharm Ltd.
- Pharmaceutical compositions comprising meloxicam8 Oct 2026US 2026/0306635 A1Axsome Therapeutics, Inc.
- Methods of treating migraine1 Oct 2026US 2026/0294881 A1Allergan Pharmaceuticals International Limited
- Compositions comprising cannabinoids and methods of use thereof1 Oct 2026US 2026/0294938 A1Schedule 1 Therapeutics, Inc.
- Methods of treating migraine24 Sep 2026US 2026/0284021 A1Allergan Pharmaceuticals International Limited
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Dual variable domain immunoglobulin and uses thereof391US 7,612,181 B2Abbott Laboratories · 2009
- Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents342US 6,309,663 B1Lipocine Inc. · 2001